Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Antonio Cusi

Psychiatry Jacksonville, NC Medical Doctor

NPI 1487643151 CMS profile 158251

200 Tarpon Trl, Jacksonville, NC 28546

Open in the dashboard

General payments

$147,189

660 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Antonio Cusi of Jacksonville, NC is reported in the CMS Open Payments database as having received $147,189 across 660 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $20,637 21
2022 General $63,613 49
2021 General $16,661 145
2020 General $14,481 198
2019 General $31,798 247

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Antonio Cusi
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Antonio Cusi were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Antonio Cusi Psychiatry median Middle half National median
2019 $31,798 $184 $59–$605 $163
2020 $14,481 $119 $36–$372 $114
2021 $16,661 $143 $43–$576 $132
2022 $63,613 $153 $50–$590 $149
2023 $20,637 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. AbbVie, Inc. $98,993 133 payments
  2. Allergan Inc. $15,285 100 payments
  3. Avanir Pharmaceuticals, Inc. $10,784 30 payments
  4. Otsuka America Pharmaceutical, Inc. $9,092 48 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $4,843 20 payments
  6. Validus Pharmaceuticals LLC $1,835 22 payments
  7. ITI, Inc. $1,245 31 payments
  8. Teva Pharmaceuticals USA, Inc. $652 38 payments
  9. Lundbeck LLC $528 34 payments
  10. Neurocrine Biosciences, Inc. $419 10 payments
  11. Other $3,513 194 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $112,949 53 payments
  2. Travel and Lodging $22,382 36 payments
  3. Food and Beverage $10,057 564 payments
  4. Honoraria $1,500 1 payment
  5. Education $299 5 payments
  6. Gift $3 1 payment
Products named General payments · program years 2019–2023
  1. VRAYLAR Neuroscience $98,905 124 payments
  2. VRAYLAR Neuroscience $15,259 94 payments
  3. NUEDEXTA $10,784 30 payments
  4. REXULTI $8,703 32 payments
  5. Trintellix $4,515 7 payments
  6. Equetro $1,835 22 payments
  7. CAPLYTA $1,245 31 payments
  8. AUSTEDO $456 36 payments
  9. ABILIFY MAINTENA $389 16 payments
  10. Dayvigo $358 16 payments
  11. Other $6,553 363 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

660 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record